180 related articles for article (PubMed ID: 33512257)
1. Increased Toxicity Among Adolescents and Young Adults Compared with Children Hospitalized with Acute Lymphoblastic Leukemia at Children's Hospitals in the United States.
Gupta A; Damania RC; Talati R; O'Riordan MA; Matloub YH; Ahuja SP
J Adolesc Young Adult Oncol; 2021 Dec; 10(6):645-653. PubMed ID: 33512257
[No Abstract] [Full Text] [Related]
2. Length of stay and treatment-related complications are similar in pediatric and AYA patients with bone sarcoma in United States children's hospitals.
Audino AN; Yeager ND; Asti L; Miao Y; O'Brien SH
Pediatr Blood Cancer; 2013 Mar; 60(3):415-9. PubMed ID: 22706952
[TBL] [Abstract][Full Text] [Related]
3. Increased Health Care Utilization and Costs during Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndromes in Adolescents and Young Adults Compared with Children: A Multicenter Study.
Rangarajan HG; Smith LC; Stanek JR; Hall M; Abu-Arja R; Auletta JJ; O'Brien SH
Biol Blood Marrow Transplant; 2019 May; 25(5):1031-1038. PubMed ID: 30625391
[TBL] [Abstract][Full Text] [Related]
4. Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study.
Muffly L; Lichtensztajn D; Shiraz P; Abrahão R; McNeer J; Stock W; Keegan T; Gomez SL
Cancer; 2017 Jan; 123(1):122-130. PubMed ID: 27622953
[TBL] [Abstract][Full Text] [Related]
5. Association of weekend admission with hospital length of stay, time to chemotherapy, and risk for respiratory failure in pediatric patients with newly diagnosed leukemia at freestanding US children's hospitals.
Goodman EK; Reilly AF; Fisher BT; Fitzgerald J; Li Y; Seif AE; Huang YS; Bagatell R; Aplenc R
JAMA Pediatr; 2014 Oct; 168(10):925-31. PubMed ID: 25155012
[TBL] [Abstract][Full Text] [Related]
6. Acute lymphoblastic leukemia in adolescents and young adults.
Rytting ME; Jabbour EJ; O'Brien SM; Kantarjian HM
Cancer; 2017 Jul; 123(13):2398-2403. PubMed ID: 28328172
[TBL] [Abstract][Full Text] [Related]
7. Improved Outcome of a Pediatric-Inspired Protocol for High-Risk Adolescent and Young Adult Acute Lymphoblastic Leukemia Patients Using Peg-Asparaginase and Escalating Dose of Methotrexate: Tolerability and Outcome.
Hanbali A; Kotb A; El Fakih R; Alfraih F; Ahmed SO; Shaheen M; Hashmi S; Alhayli S; Alahmari A; Riash MA; Rasheed W; Alzahrani H; Alsharif F; Chaudhri N; Almohareb F; Aljurf M
Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):670-677. PubMed ID: 31377206
[TBL] [Abstract][Full Text] [Related]
8. Adolescent and young adult enrollment to a National Cancer Institute-sponsored National Clinical Trials Network Research Group over 25 years.
Unger JM; Beauchemin M; Hershman DL
Cancer; 2021 Dec; 127(24):4574-4584. PubMed ID: 34351619
[TBL] [Abstract][Full Text] [Related]
9. Retrospective study of Dana Farber Consortium Protocol in newly diagnosed Egyptian adolescents and young adults with acute lymphoblastic leukemia: Tanta experience.
Elashtokhy HEA; Elgohary HE; Eldeep BB; Gaber SM; Elbedewy TA
J Egypt Natl Canc Inst; 2021 Apr; 33(1):9. PubMed ID: 33826046
[TBL] [Abstract][Full Text] [Related]
10. Establishment of an 11-year cohort of 8733 pediatric patients hospitalized at United States free-standing children's hospitals with de novo acute lymphoblastic leukemia from health care administrative data.
Fisher BT; Harris T; Torp K; Seif AE; Shah A; Huang YS; Bailey LC; Kersun LS; Reilly AF; Rheingold SR; Walker D; Li Y; Aplenc R
Med Care; 2014 Jan; 52(1):e1-6. PubMed ID: 22410405
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Hospital Length of Stay on Readmissions for Children With Newly Diagnosed Acute Lymphoblastic Leukemia.
Wedekind MF; Dennis R; Sturm M; Koch T; Stanek J; O'Brien SH
J Pediatr Hematol Oncol; 2016 Jul; 38(5):329-33. PubMed ID: 26989914
[TBL] [Abstract][Full Text] [Related]
12. The current treatment approach to adolescents and young adults with acute lymphoblastic leukemia (AYA-ALL): challenges and considerations.
Jain H; Rajendra A; Sengar M; Goli VB; Thorat J; Muthuluri H; Tongaonkar AH; Kota KK; Gupta H; Sharma N; Eipe T; Mehta H
Expert Rev Anticancer Ther; 2022 Aug; 22(8):845-860. PubMed ID: 35734814
[TBL] [Abstract][Full Text] [Related]
13. How I treat acute lymphoblastic leukemia in older adolescents and young adults.
Curran E; Stock W
Blood; 2015 Jun; 125(24):3702-10. PubMed ID: 25805810
[TBL] [Abstract][Full Text] [Related]
14. Augmented Berlin-Frankfurt-Münster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL).
Rytting ME; Thomas DA; O'Brien SM; Ravandi-Kashani F; Jabbour EJ; Franklin AR; Kadia TM; Pemmaraju N; Daver NG; Ferrajoli A; Garcia-Manero G; Konopleva MY; Cortes JE; Borthakur G; Garris R; Cardenas-Turanzas M; Schroeder K; Jorgensen JL; Kornblau SM; Kantarjian HM
Cancer; 2014 Dec; 120(23):3660-8. PubMed ID: 25042398
[TBL] [Abstract][Full Text] [Related]
15. The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study.
Gupta S; Pole JD; Baxter NN; Sutradhar R; Lau C; Nagamuthu C; Nathan PC
Cancer Med; 2019 May; 8(5):2095-2103. PubMed ID: 30912628
[TBL] [Abstract][Full Text] [Related]
16. [Treatment strategy for acute lymphoblastic leukemia in adolescent and young adults].
Yamazaki E
Rinsho Ketsueki; 2022; 63(7):826-832. PubMed ID: 35922954
[TBL] [Abstract][Full Text] [Related]
17. Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232.
Burke MJ; Devidas M; Chen Z; Salzer WL; Raetz EA; Rabin KR; Heerema NA; Carroll AJ; Gastier-Foster JM; Borowitz MJ; Wood BL; Winick NJ; Carroll WL; Hunger SP; Loh ML; Larsen EC
Leukemia; 2022 Mar; 36(3):648-655. PubMed ID: 34725453
[TBL] [Abstract][Full Text] [Related]
18. Improved survival in adolescents and young adults (AYA) patients aged 14-55 years with acute lymphoblastic leukemia using pediatric-inspired protocol - a retrospective analysis of a real-world experience in 79 of patients treated at a national tertiary care referral center.
Hanbali A; Kotb A; Fakih RE; Alfraih F; Ahmed SO; Shaheen M; Alhayli S; Alahmari A; Alotaibi A; Alshaibani A; Riash MA; Deeba F; Asif M; Rasheed W; Alzahrani H; Alsharif F; Chaudhri N; Almohareb F; Aljurf M
Leuk Res Rep; 2021; 16():100270. PubMed ID: 34631407
[TBL] [Abstract][Full Text] [Related]
19. Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
Brown PA; Ji L; Xu X; Devidas M; Hogan LE; Borowitz MJ; Raetz EA; Zugmaier G; Sharon E; Bernhardt MB; Terezakis SA; Gore L; Whitlock JA; Pulsipher MA; Hunger SP; Loh ML
JAMA; 2021 Mar; 325(9):833-842. PubMed ID: 33651090
[TBL] [Abstract][Full Text] [Related]
20. Adolescents with acute lymphoblastic leukemia treated at pediatric versus adult hospitals.
Pole JD; Alibhai SM; Ethier MC; Teuffel O; Portwine C; Zelcer S; Johnston DL; Silva M; Alexander S; Brandwein JM; Sung L
Ann Oncol; 2013 Mar; 24(3):801-6. PubMed ID: 23108950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
